Inclusion Criteria:  Male or female patients, ≥18 years of age, being treated with Lucentis® for any approved indication in the local Lucentis® SmPC Written informed consent  Exclusion Criteria:  As described in Lucentis® SmPC Participation in any other clinical study or NIS with Lucentis® as the investigational drug (such as OCEAN or LUMINOUS)